Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2018 Filed Sep 18, 2018 23:54 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 4,400 | $145.27 | $639,174.36 |
DisclosureSEC source: 0001093557-18-000205 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,105 F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $145.00 to $145.70. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:54 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 600 | $144.46 | $86,677.08 |
DisclosureSEC source: 0001093557-18-000205 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,505 F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $144.00 to $144.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 20:35 UTC |
Leach Jacob StevenSVP, Research & Development
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001093557-18-000203 · edgardoc.xml · derivative · entry 4 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 20:35 UTC |
Leach Jacob StevenSVP, Research & Development
|
Exercise / conversionCommon Stock | 15,000 | $5.92 | $88,800.00 |
DisclosureSEC source: 0001093557-18-000203 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Included in this number are 46,994 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 11,567 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,334 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 11, 2018 Filed Sep 14, 2018 01:48 UTC |
Blackford Quentin S.EVP, CFO, PFO & PAO
|
SaleCommon Stock | 3,680 | $148.22 | $545,453.65 |
DisclosureSEC source: 0000899243-18-024485 · doc4.xml · nonDerivative · entry 4 Blackford Quentin S. · CIK 0001612451 · EVP, CFO, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,131 F1 · shares: On August 7, 2018, Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $147.75 to $148.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 85,271 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| September 11, 2018 Filed Sep 14, 2018 01:48 UTC |
Blackford Quentin S.EVP, CFO, PFO & PAO
|
SaleCommon Stock | 1,460 | $147.41 | $215,213.49 |
DisclosureSEC source: 0000899243-18-024485 · doc4.xml · nonDerivative · entry 3 Blackford Quentin S. · CIK 0001612451 · EVP, CFO, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,811 F1 · shares: On August 7, 2018, Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $146.75 to $147.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 85,271 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| September 11, 2018 Filed Sep 14, 2018 01:48 UTC |
Blackford Quentin S.EVP, CFO, PFO & PAO
|
SaleCommon Stock | 1,200 | $146.15 | $175,377.96 |
DisclosureSEC source: 0000899243-18-024485 · doc4.xml · nonDerivative · entry 2 Blackford Quentin S. · CIK 0001612451 · EVP, CFO, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,271 F1 · shares: On August 7, 2018, Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $145.68 to $146.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 85,271 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| September 11, 2018 Filed Sep 14, 2018 01:48 UTC |
Blackford Quentin S.EVP, CFO, PFO & PAO
|
SaleCommon Stock | 2,100 | $145.23 | $304,982.58 |
DisclosureSEC source: 0000899243-18-024485 · doc4.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · EVP, CFO, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,471 F1 · shares: On August 7, 2018, Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $144.54 to $145.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 85,271 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
MOY JEFFREYSVP, Operations
|
SaleCommon Stock | 5,736 | $143.35 | $822,255.60 |
DisclosureSEC source: 0001093557-18-000201 · edgardoc.xml · nonDerivative · entry 5 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 16,711 F5 · shares: On May 29, 2018, Mr. Moy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Moy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
MOY JEFFREYSVP, Operations
|
OtherCommon Stock | 17,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-18-000201 · edgardoc.xml · nonDerivative · entry 4 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 22,447 F3 · shares: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units. F4 · ownership.nature: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
MOY JEFFREYSVP, Operations
|
OtherCommon Stock | 17,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-18-000201 · edgardoc.xml · nonDerivative · entry 3 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,534 F3 · shares: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 46,534 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,500 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
MOY JEFFREYSVP, Operations
|
SaleCommon Stock | 2,762 | $143.76 | $397,051.86 |
DisclosureSEC source: 0001093557-18-000201 · edgardoc.xml · nonDerivative · entry 2 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,920 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 46,534 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,500 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
MOY JEFFREYSVP, Operations
|
SaleCommon Stock | 1,832 | $143.76 | $263,359.53 |
DisclosureSEC source: 0001093557-18-000201 · edgardoc.xml · nonDerivative · entry 1 MOY JEFFREY · CIK 0001446422 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,682 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 46,534 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,500 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,180 | $143.76 | $457,141.54 |
DisclosureSEC source: 0001093557-18-000200 · edgardoc.xml · nonDerivative · entry 3 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,804 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:22 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,303 | $143.76 | $331,068.23 |
DisclosureSEC source: 0001093557-18-000200 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,984 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:21 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 3,180 | $143.76 | $457,141.54 |
DisclosureSEC source: 0001093557-18-000199 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,105 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:21 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 2,407 | $143.76 | $346,018.77 |
DisclosureSEC source: 0001093557-18-000199 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,285 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:21 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 2,303 | $143.76 | $331,068.23 |
DisclosureSEC source: 0001093557-18-000198 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,974 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:21 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 3,180 | $143.76 | $457,141.54 |
DisclosureSEC source: 0001093557-18-000198 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,277 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC |
Murphy Patrick MichaelVP, Legal Aff & Chf Compl Ofcr
|
SaleCommon Stock | 400 | $143.35 | $57,340.00 |
DisclosureSEC source: 0001093557-18-000197 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,308 F3 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC |
Murphy Patrick MichaelVP, Legal Aff & Chf Compl Ofcr
|
SaleCommon Stock | 1,021 | $143.76 | $146,774.06 |
DisclosureSEC source: 0001093557-18-000197 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,708 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC |
Murphy Patrick MichaelVP, Legal Aff & Chf Compl Ofcr
|
SaleCommon Stock | 951 | $143.76 | $136,711.20 |
DisclosureSEC source: 0001093557-18-000197 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,729 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC |
Leach Jacob StevenSVP, Research & Development
|
SaleCommon Stock | 2,678 | $143.76 | $384,976.43 |
DisclosureSEC source: 0001093557-18-000196 · edgardoc.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,284 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 46,994 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 11,567 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,334 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC |
Leach Jacob StevenSVP, Research & Development
|
SaleCommon Stock | 1,936 | $143.76 | $278,310.07 |
DisclosureSEC source: 0001093557-18-000196 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,962 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 46,994 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 11,567 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,334 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:19 UTC |
ACE HEATHER SSVP Human Resources
|
SaleCommon Stock | 1,832 | $143.76 | $263,359.53 |
DisclosureSEC source: 0001093557-18-000195 · edgardoc.xml · nonDerivative · entry 1 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,339 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:19 UTC |
Abbey DonaldEVP, Quality & Regulatory Afrs
|
SaleCommon Stock | 2,303 | $143.76 | $331,068.23 |
DisclosureSEC source: 0001093557-18-000194 · edgardoc.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,639 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,161 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · derivative · entry 7 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,484 Underlying: Common Stock · 11,161 shares Expires 2019-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 6,802 | $143.76 | $977,822.87 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · nonDerivative · entry 6 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,837 F6 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 7,532 | $143.76 | $1,082,764.17 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · nonDerivative · entry 5 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,639 F6 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F1 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 3,761 | $144.04 | $541,724.29 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · nonDerivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,171 F2 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $143.78 to $144.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 5,900 | $143.35 | $845,791.55 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,932 F2 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $142.78 to $143.77. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 1,500 | $142.31 | $213,470.55 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,832 F2 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $141.77 to $142.72. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:17 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
Exercise / conversionCommon Stock | 11,161 | $4.58 | $51,117.38 |
DisclosureSEC source: 0001093557-18-000192 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:18 UTC |
Blackford Quentin S.EVP, CFO, PFO & PAO
|
SaleCommon Stock | 7,149 | $143.76 | $1,027,705.92 |
DisclosureSEC source: 0001093557-18-000193 · edgardoc.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · EVP, CFO, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,571 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 85,271 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| August 31, 2018 Filed Sep 13, 2018 01:22 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
OtherCommon Stock | 20,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-18-000200 · edgardoc.xml · nonDerivative · entry 4 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,830 F1 · shares: Shares were transferred from direct ownership to ownership under the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. F4 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| August 31, 2018 Filed Sep 13, 2018 01:22 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
OtherCommon Stock | 20,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-18-000200 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,287 F1 · shares: Shares were transferred from direct ownership to ownership under the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. F2 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| August 24, 2018 Filed Aug 29, 2018 00:32 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 5,000 | $136.47 | $682,359.00 |
DisclosureSEC source: 0001093557-18-000181 · edgardoc.xml · nonDerivative · entry 1 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Foundation Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $136.47 to $136.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: Shares held by The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 23:01 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1,000 | $137.50 | $137,503.00 |
DisclosureSEC source: 0001093557-18-000179 · edgardoc.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,095 F1 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:58 UTC |
Leach Jacob StevenSVP, Research & Development
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001093557-18-000178 · edgardoc.xml · derivative · entry 8 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2018-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:58 UTC |
Leach Jacob StevenSVP, Research & Development
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 10,577 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001093557-18-000178 · edgardoc.xml · derivative · entry 7 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,577 shares Expires 2018-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:58 UTC |
Leach Jacob StevenSVP, Research & Development
|
SaleCommon Stock | 10,000 | $138.32 | $1,383,173.00 |
DisclosureSEC source: 0001093557-18-000178 · edgardoc.xml · nonDerivative · entry 4 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,878 F1 · price: This transaction was executed in multiple trades at prices ranging from $138.19 to $138.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 56,182 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 15,422 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 10,667 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:58 UTC |
Leach Jacob StevenSVP, Research & Development
|
Exercise / conversionCommon Stock | 10,000 | $5.92 | $59,200.00 |
DisclosureSEC source: 0001093557-18-000178 · edgardoc.xml · nonDerivative · entry 3 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:58 UTC |
Leach Jacob StevenSVP, Research & Development
|
SaleCommon Stock | 10,577 | $138.32 | $1,462,982.08 |
DisclosureSEC source: 0001093557-18-000178 · edgardoc.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,878 F1 · price: This transaction was executed in multiple trades at prices ranging from $138.19 to $138.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 56,182 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 15,422 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 10,667 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 22:58 UTC |
Leach Jacob StevenSVP, Research & Development
|
Exercise / conversionCommon Stock | 10,577 | $3.19 | $33,740.63 |
DisclosureSEC source: 0001093557-18-000178 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Feb 15, 2019 22:19 UTC |
ALTMAN STEVEN RDirector
|
OtherCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000031 · edgardoc.xml · nonDerivative · entry 4 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 57,855 F2 · shares: Shares were transferred from the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, to ownership under The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent. Read SEC document |
| August 24, 2018 Filed Feb 15, 2019 22:19 UTC |
ALTMAN STEVEN RDirector
|
OtherCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000031 · edgardoc.xml · nonDerivative · entry 2 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Foundation Disclosed balance after: 5,000 F2 · shares: Shares were transferred from the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, to ownership under The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:21 UTC |
ACE HEATHER SSVP Human Resources
|
Disposition to issuerCommon Stock | 3,061 | $141.59 | $433,411.89 |
DisclosureSEC source: 0001093557-18-000175 · edgardoc.xml · nonDerivative · entry 1 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,171 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Included in this number are 58,431 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,588 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:20 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $143.09 | $14,309.00 |
DisclosureSEC source: 0001093557-18-000174 · edgardoc.xml · nonDerivative · entry 3 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 0 F1 · shares: On May 16, 2017 Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:20 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 550 | $140.52 | $77,287.27 |
DisclosureSEC source: 0001093557-18-000174 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 100 F1 · shares: On May 16, 2017 Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $140.27 to $141.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:20 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,934 | $139.73 | $270,236.27 |
DisclosureSEC source: 0001093557-18-000174 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 650 F1 · shares: On May 16, 2017 Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $139.24 to $140.24. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.